![]() |
|
|
Vol. 62, Issue 5, 1228-1237, November 2002
Department of Physiology, National Taiwan University College of
Medicine (Y.-C.Y., C.-C.K.); and Department of Neurology, National
Taiwan University Hospital (C.-C.K.)
Use-dependent block of Na+ channels plays an important role
in the action of many medications, including the anticonvulsants phenytoin, carbamazepine, and lamotrigine. These anticonvulsants all
slowly yet selectively bind to a common receptor site in inactivated but not resting Na+ channels, constituting the molecular
basis of the use-dependent block. However, it remains unclear what
channel gating process "makes" the receptor, where the receptor is
located, and how the slow drug binding rate (to the inactivated
channels) is contrived. Imipramine has a diphenyl structural motif
almost identical to that in carbamazepine (a dibenzazepine tricyclic
compound), as well as a tertiary amine chain similar to that in many
prototypical local anesthetics, and has also been reported to inhibit
Na+ channels in a use-dependent fashion. We found that
imipramine selectively binds to the inactivated (dissociation constant
~1.3 µM) rather than the resting Na+ channels
(dissociation constant >130 µM). Moreover, imipramine rapidly blocks
open Na+ channels, with a binding rate ~70-fold faster
than its binding to the inactivated channels. Similarly, carbamazepine
and diphenhydramine are open Na+ channel blockers with
faster binding rates to the open than to the inactivated channels.
These findings indicate that the anticonvulsant receptor responsible
for the use-dependent block of Na+ channels is located in
or near the pore (most likely in the pore mouth) and is made suitable
for drug binding during channel activation. The receptor, however,
continually changes its conformation in the subsequent gating process,
causing the slower drug binding rates to the inactivated
Na+ channels.
This article has been cited by other articles:
![]() |
N. Lenkey, R. Karoly, J. P. Kiss, B. K. Szasz, E. S. Vizi, and A. Mike The Mechanism of Activity-Dependent Sodium Channel Inhibition by the Antidepressants Fluoxetine and Desipramine Mol. Pharmacol., December 1, 2006; 70(6): 2052 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Benjamin, F. Pruthi, S. Olanrewaju, V. I. Ilyin, G. Crumley, E. Kutlina, K. J. Valenzano, and R. M. Woodward State-Dependent Compound Inhibition of Nav1.2 Sodium Channels Using the FLIPR Vm Dye: On-Target and Off-Target Effects of Diverse Pharmacological Agents J Biomol Screen, February 1, 2006; 11(1): 29 - 39. [Abstract] [PDF] |
||||
![]() |
M. D. Fuller, Z.-R. Zhang, G. Cui, and N. A. McCarty The Block of CFTR by Scorpion Venom is State-Dependent Biophys. J., December 1, 2005; 89(6): 3960 - 3975. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Yang and C.-C. Kuo An Inactivation Stabilizer of the Na+ Channel Acts as an Opportunistic Pore Blocker Modulated by External Na+ J. Gen. Physiol., April 25, 2005; 125(5): 465 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Luca, S. Talon, M. De Bellis, J.-F. Desaphy, G. Lentini, F. Corbo, A. Scilimati, C. Franchini, V. Tortorella, and D. C. Camerino Optimal Requirements for High Affinity and Use-Dependent Block of Skeletal Muscle Sodium Channel by N-Benzyl Analogs of Tocainide-Like Compounds Mol. Pharmacol., October 1, 2003; 64(4): 932 - 945. [Abstract] [Full Text] [PDF] |
||||